BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 28550488)

  • 1. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
    Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
    Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of preoperative
    Hu J; Zhang K; Yan Y; Zang Y; Wang Y; Xue F
    Arch Gynecol Obstet; 2019 Sep; 300(3):519-529. PubMed ID: 31165242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
    Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
    Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
    Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of
    Legros M; Margueritte F; Tardieu A; Deluche E; Mbou VB; Lacorre A; Ceuca A; Aubard Y; Monteil J; Sallee C; Gauthier T
    Anticancer Res; 2019 Feb; 39(2):619-625. PubMed ID: 30711937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer.
    Suzuki R; Miyagi E; Takahashi N; Sukegawa A; Suzuki A; Koike I; Sugiura K; Okamoto N; Inoue T; Hirahara F
    Int J Gynecol Cancer; 2007; 17(4):890-6. PubMed ID: 17343574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel Lymph Node Biopsy in Endometrial Cancer--Comparison of 2 Detection Methods.
    Sawicki S; Lass P; Wydra D
    Int J Gynecol Cancer; 2015 Jul; 25(6):1044-50. PubMed ID: 25853384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
    Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G
    Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
    Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
    Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of PET/CT in determining lymph node metastasis of endometrial cancer.
    Budak E; Yanarateş A
    Ginekol Pol; 2019; 90(10):565-570. PubMed ID: 31686412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative pelvic MRI and 2-[
    Fasmer KE; Gulati A; Dybvik JA; Wagner-Larsen KS; Lura N; Salvesen Ø; Forsse D; Trovik J; Pijnenborg JMA; Krakstad C; Haldorsen IS
    Eur Radiol; 2023 Jan; 33(1):221-232. PubMed ID: 35763096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.